/PRNewswire/ PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will present a company overview at the following conferences: Wells.
PTC Therapeutics (NASDAQ:NASDAQ:PTCT) Q2 2022 Earnings Conference Call August 4, 2022 16:30 ET Company Participants Kylie O'Keefe - Senior Vice President, Head of Global Commercial &.
/PRNewswire/ PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced a corporate update and financial results for the second quarter ending June 30, 2022. "We.
/PRNewswire/ PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will host a webcast conference call to report its second quarter 2022.
Upstaza™ Granted Marketing Authorization by European Commission as First Disease-Modifying Treatment for AADC Deficiency prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.